Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06618144 · ClinicalTrials.gov registry record · NA
Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access
A NA study of Early Pregnancy Loss and Early Pregnancy, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT06618144: Completed NA study of Early Pregnancy Loss and Early Pregnancy, sponsored by University of Pennsylvania.
NCT06618144 is a NA study of Early Pregnancy Loss and Early Pregnancy that has completed, run by University of Pennsylvania. The registered enrollment target is 350 participants, above the 107-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (227% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06618144, a NA study of Early Pregnancy Loss and Early Pregnancy, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project, Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access (CIRCA), is to engage patients in care early in pregnancy (before prenatal care starts) and safely triage concerns to PEACE to reduce unnecessary emergency department visits.
Primary Outcome
Time from first contact to initiating pregnancy related care
Conditions Studied
Interventions
- OTHER Texting platform
Study Locations (1)
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2024-08-20 |
| Est. Completion | 2025-09-21 |
| Phase | NA |
What the finished NCT06618144 record still lists
NCT06618144 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, above the 107-participant average among 3 other Early Pregnancy Loss trials with a reported enrollment target (227% higher).
The record links to 2 conditions, with Early Pregnancy Loss appearing as the primary indexed condition, and to 1 intervention - of which Texting platform is the first listed.
NCT06618144 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06618144 about?
NCT06618144 is a clinical study titled "Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access". The goal of this project, Conversational Artificial Intelligence (AI) to Improve PeRiconception Care Access (CIRCA), is to engage patients in care early in pregnancy (before prenatal care starts) and safely triage concerns to PEACE to reduce unnecessary emergency department visits.
What is the current status of trial NCT06618144?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2024-08-20. Estimated completion is 2025-09-21.
What conditions does trial NCT06618144 study?
This clinical trial studies the following conditions: Early Pregnancy Loss, Early Pregnancy.
What interventions are being tested in trial NCT06618144?
The interventions under investigation include: Texting platform (OTHER).
Who is sponsoring clinical trial NCT06618144?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06618144 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Pregnancy Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI